ABBV: third_quarter 2026 lobbying report

{"url":"https://lda.gov/api/v1/filings/fbc1ec8c-2170-4fb3-8a1f-58c49833c749/","filing_uuid":"fbc1ec8c-2170-4fb3-8a1f-58c49833c749","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/fbc1ec8c-2170-4fb3-8a1f-58c49833c749/print/","filing_document_content_type":"text/html","income":"80000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Stacey Scholl","dt_posted":"2026-10-15T14:38:53-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"800 Maine Ave. SW Floor 7","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20024","registrant":{"id":75557,"url":"https://lda.gov/api/v1/registrants/75557/","house_registrant_id":36051,"name":"CORNERSTONE GOVERNMENT AFFAIRS, INC.","description":"Government relations and consulting.","address_1":"800 Maine Ave. SW Floor 7","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20024","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"STACEY SCHOLL","contact_telephone":"+1 202-370-1015","dt_updated":"2026-07-15T15:23:57.752080-04:00"},"client":{"id":210732,"url":"https://lda.gov/api/v1/clients/210732/","client_id":1008718,"name":"ABBVIE INC.","general_description":"Biopharmaceutical company","client_government_entity":false,"client_self_select":null,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2021-04-16"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"International tax issues and pharmaceutical pricing and access issues, and patent issues.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":63745,"prefix":null,"prefix_display":null,"first_name":"TODD","nickname":null,"middle_name":null,"last_name":"WEBSTER","suffix":null,"suffix_display":null},"covered_position":"Communications Senate Member Office (Murray, Daschle), Chief of Staff Senate Member Office (Coons)","new":false},{"lobbyist":{"id":69536,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"SANDELL","suffix":null,"suffix_display":null},"covered_position":"Tax Counsel, Legislative Assistant; Ways and Means Committee (Camp, Ryan, Brady)","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"International tax issues and pharmaceutical pricing and access issues, and patent issues.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":63745,"prefix":null,"prefix_display":null,"first_name":"TODD","nickname":null,"middle_name":null,"last_name":"WEBSTER","suffix":null,"suffix_display":null},"covered_position":"Communications Senate Member Office (Murray, Daschle), Chief of Staff Senate Member Office (Coons)","new":false},{"lobbyist":{"id":69536,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"SANDELL","suffix":null,"suffix_display":null},"covered_position":"Tax Counsel, Legislative Assistant; Ways and Means Committee (Camp, Ryan, Brady)","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}